Lymphoblastic (diffuse) lymphoma is a type of aggressive non-Hodgkin lymphoma characterized by the proliferation of immature lymphoid cells. This condition primarily affects the intrathoracic lymph nodes, leading to significant clinical manifestations such as respiratory distress and mediastinal mass effects. Accurate coding with ICD-10 Code C83.52 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
What is ICD-10 Code C83.52 for Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes?
ICD-10 Code C83.52 specifically denotes lymphoblastic (diffuse) lymphoma affecting the intrathoracic lymph nodes. This aggressive lymphoma is characterized by the presence of immature lymphocytes and can lead to significant complications if not diagnosed and treated promptly. This code should be used in clinical documentation and billing when a patient presents with symptoms indicative of this condition, ensuring accurate representation of the patient's diagnosis.
ICD-10 Code C83.52 – Clinical Definition and Explanation of Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
Lymphoblastic (diffuse) lymphoma, classified under ICD-10 Code C83.52, is a hematological malignancy that arises from immature lymphoid cells. It typically presents in adolescents and young adults and requires immediate medical intervention due to its aggressive nature. The condition can lead to severe respiratory complications and requires prompt diagnosis and treatment.
Key Clinical Features:
- Presence of a mediastinal mass causing respiratory symptoms.
- Lymphadenopathy in the thoracic region.
- Symptoms of systemic illness such as fever, night sweats, and weight loss.
- Bone marrow involvement may lead to cytopenias.
ICD-10 Code C83.52 for Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes – SOAP Notes & Clinical Use
In SOAP notes, ICD-10 Code C83.52 is utilized to document the diagnosis of lymphoblastic (diffuse) lymphoma affecting the intrathoracic lymph nodes. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
What Does ICD-10 Code C83.52 for Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes Mean in SOAP Notes?
ICD-10 Code C83.52 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of lymphoblastic (diffuse) lymphoma. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C83.52 – Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
The management of lymphoblastic (diffuse) lymphoma requires urgent medical attention, often necessitating hospitalization for intensive treatment.
Antibiotic Therapy:
- Not applicable as this is not an infectious condition.
Supportive Care:
- Chemotherapy regimens such as hyper-CVAD.
- Supportive transfusions for anemia or thrombocytopenia.
- Management of symptoms such as pain and respiratory distress.
Infection Control:
- Implement standard precautions to prevent infections.
- Monitor for febrile neutropenia during chemotherapy.
How to Document Symptoms of Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes (ICD-10 C83.52) in SOAP Notes
Subjective:
- Patient reports persistent cough and shortness of breath.
- History of night sweats and unexplained weight loss.
- Complaints of chest pain and fatigue.
Objective:
- Physical examination reveals lymphadenopathy in the cervical and axillary regions.
- Chest X-ray shows a large mediastinal mass.
- Laboratory tests indicate elevated white blood cell count with immature lymphocytes.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes (ICD-10 Code C83.52)
Assessment:
- Diagnosis: Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes, severe.
- ICD-10 Code: C83.52.
- Contributing factors include age and presentation of systemic symptoms.
Plan:
- Initiate chemotherapy with a regimen such as hyper-CVAD.
- Provide education on potential side effects and symptom management.
- Schedule follow-up appointments for monitoring treatment response.
Treatment & Plan Section for ICD-10 Code C83.52 – Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
- First-line treatment includes multi-agent chemotherapy.
- Consider hematopoietic stem cell transplant for eligible patients.
- Regular monitoring of blood counts and response to therapy.
- Patient education on recognizing signs of infection and complications.
Using ICD-10 Code C83.52 for Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
- Use C83.52 in conjunction with appropriate CPT codes for chemotherapy administration.
- Document treatment plans that align with clinical guidelines to support billing.
- Include relevant patient history and presenting complaints to justify the diagnosis.
Related ICD-10 Codes Often Used with Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
ICD-10 Code C83.52 in Medical Billing and Insurance for Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
ICD-10 Code C83.52 is critical for accurate billing in hospital, ER, or infectious disease care settings.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
- Use C83.52 in settings where patients present with symptoms of lymphoblastic lymphoma.
- Ensure that all chart elements align with the diagnosis for compliance.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 36415 | Collection of venous blood by venipuncture. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.52 for Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
What are the common symptoms of lymphoblastic lymphoma?
Common symptoms include fever, night sweats, weight loss, and respiratory distress due to mediastinal mass effects. Patients may also experience lymphadenopathy and fatigue.
How is lymphoblastic lymphoma diagnosed?
Diagnosis typically involves imaging studies such as chest X-rays or CT scans, along with biopsy of affected lymph nodes to confirm the presence of immature lymphoid cells.
What is the treatment for lymphoblastic lymphoma?
Treatment usually involves intensive chemotherapy regimens, and in some cases, hematopoietic stem cell transplantation may be considered for eligible patients.
Is lymphoblastic lymphoma contagious?
No, lymphoblastic lymphoma is not contagious. It is a malignancy arising from genetic mutations in lymphoid cells and cannot be transmitted from person to person.
